Ixaka
Gaby is the founder and Managing Director of Wharton Asset Management, a private London based family office specialising in private equity investment in diverse sectors including healthcare and biotechnology. Gaby has over 20 years of experience in finance and investment. He is the co-founder of Rexgenero bringing together the licence partner, the investors and management team within Rexgenero. He represents the principal shareholders and funders of Rexgenero.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ixaka
1 followers
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.